Javier Camacho

Cp 07360
Mexico, MEX 07360, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Antineoplastic Activity of the Combination Loratadine-Simvastatin-Gefitinib in HPV-Positive Cervical Cancer Cells: In Vitro and In Vivo Studies.

Antineoplastic Activity of the Combination Loratadine-Simvastatin-Gefitinib in HPV-Positive Cervical Cancer Cells: In Vitro and In Vivo Studies.

Journal: Cancers

Published: June 27, 2026

Cannabidiol-Ion Channel Interactions Represent a Promising Preventive and Therapeutic Strategy in Hepatocellular Carcinoma.

Cannabidiol-Ion Channel Interactions Represent a Promising Preventive and Therapeutic Strategy in Hepatocellular Carcinoma.

Journal: Pathophysiology : the official journal of the International Society for Pathophysiology

Published: November 29, 2025

The Effects of Nebivolol-Gefitinib-Loratadine Against Lung Cancer Cell Lines.

The Effects of Nebivolol-Gefitinib-Loratadine Against Lung Cancer Cell Lines.

Journal: In vivo (Athens, Greece)

Published: August 10, 2024

Altered expression and localization of nuclear envelope proteins in a prostate cancer cell system.

Altered expression and localization of nuclear envelope proteins in a prostate cancer cell system.

Journal: Molecular biology reports

Published: May 20, 2024

Intriguing hepatoprotective effects of sucrose on hepatocellular carcinoma pathogenesis.

Intriguing hepatoprotective effects of sucrose on hepatocellular carcinoma pathogenesis.

Journal: Scientific reports

Published: April 16, 2024

Enhancing Tamoxifen Therapy with α-Mangostin: Synergistic Antiproliferative Effects on Breast Cancer Cells and Potential Reduced Endometrial Impact.

Enhancing Tamoxifen Therapy with α-Mangostin: Synergistic Antiproliferative Effects on Breast Cancer Cells and Potential Reduced Endometrial Impact.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 10, 2023

Ion Channels and Personalized Medicine in Gynecological Cancers.

Ion Channels and Personalized Medicine in Gynecological Cancers.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 15, 2023

The Combination Sorafenib-raloxifene-loratadine as a Novel Potential Therapeutic Approach Against Human Liver Cancer.

The Combination Sorafenib-raloxifene-loratadine as a Novel Potential Therapeutic Approach Against Human Liver Cancer.

Journal: In vivo (Athens, Greece)

Published: March 09, 2023

Ion Channels as Potential Tools for the Diagnosis, Prognosis, and Treatment of HPV-Associated Cancers.

Ion Channels as Potential Tools for the Diagnosis, Prognosis, and Treatment of HPV-Associated Cancers.

Journal: Cells

Published: February 15, 2023

Annexins A2 and A5 are potential early biomarkers of hepatocarcinogenesis.

Annexins A2 and A5 are potential early biomarkers of hepatocarcinogenesis.

Journal: Scientific reports

Published: February 01, 2023

Current and novel approaches in the pharmacological treatment of hepatocellular carcinoma.

Current and novel approaches in the pharmacological treatment of hepatocellular carcinoma.

Journal: World journal of gastroenterology

Published: December 27, 2022

The Phytochemical α-Mangostin Inhibits Cervical Cancer Cell Proliferation and Tumor Growth by Downregulating E6/E7-HPV Oncogenes and KCNH1 Gene Expression.

The Phytochemical α-Mangostin Inhibits Cervical Cancer Cell Proliferation and Tumor Growth by Downregulating E6/E7-HPV Oncogenes and KCNH1 Gene Expression.

Journal: International journal of molecular sciences

Published: December 20, 2022

Showing 1-12 of 44

Last Updated: 09/26/2026